Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicansPetra Bächer, Alexander Scheffold, Maren Ziegler et al.|Cell|2019Cited by 472
Monocyte and M1 Macrophage-induced Barrier Defect Contributes to Chronic Intestinal Inflammation in IBDDonata Lissner, Britta Siegmund|Inflammatory Bowel Diseases|2015Cited by 361
An Integrated Taxonomy for Monogenic Inflammatory Bowel DiseaseChrissy Bolton, Holm H. Uhlig, Christopher S. Smillie et al.|Gastroenterology|2021Cited by 94
Anti-Adhesion Therapies in Inflammatory Bowel Disease—Molecular and Clinical AspectsSebastian Zundler, Britta Siegmund|Frontiers in Immunology|2017Cited by 69
Obefazimod in patients with moderate-to-severely active ulcerative colitis: efficacy and safety analysis from the 96-week open-label maintenance phase 2b studySéverine Vermeire, Bruce E. Sands, Josianne Nitcheu et al.|Journal of Crohn s and Colitis|2025Cited by 10